Redhill Biopharma Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Redhill Biopharma Ltd., a foreign private issuer based in Tel Aviv, Israel, on June 4, 2013. The report covers the month of June 2013 and serves to disclose a corporate presentation made at the Jefferies 2013 Global Healthcare Conference.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a conference presentation and does not contain financial statements or quantitative performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely references the delivery of an overview presentation by Mr. Guy Goldberg, Chief Business Officer, on June 3, 2013.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the conference presentation. The filing does not contain specific financial guidance, outlook projections, risk factors, contingencies, or unusual items. A webcast replay of the presentation was made available on the company's website for 30 days.
Key Facts for Investors to Verify
- Verify the content of the presentation delivered by Mr. Guy Goldberg at the Jefferies 2013 Global Healthcare Conference.
- Confirm the availability of the archived webcast replay on the company's investor relations website.
- Note that this filing contains no financial data; refer to Form 20-F for audited financial results.